Literature DB >> 21788981

Childhood brain tumors: epidemiology, current management and future directions.

Ian F Pollack1, Regina I Jakacki.   

Abstract

Brain tumors are the most common solid tumors in children. With the increasingly widespread availability of MRI, the incidence of childhood brain tumors seemed to rise in the 1980s, but has subsequently remained relatively stable. However, management of brain tumors in children has evolved substantially during this time, reflecting refinements in classification of tumors, delineation of risk groups within histological subsets of tumors, and incorporation of molecular techniques to further define tumor subgroups. Although considerable progress has been made in the outcomes of certain tumors, prognosis in other childhood brain tumor types is poor. Among the tumor groups with more-favorable outcomes, attention has been focused on reducing long-term morbidity without sacrificing survival rates. Studies for high-risk groups have examined the use of intensive therapy or novel, molecularly targeted approaches to improve disease control rates. In addition to reviewing the literature and providing an overview of the complexities in diagnosing childhood brain tumors, we will discuss advances in the treatment and categorization of several tumor types in which progress has been most apparent, as well as those in which improvements have been lacking. The latest insights from molecular correlative studies that hold potential for future refinements in therapy will also be discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21788981     DOI: 10.1038/nrneurol.2011.110

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  132 in total

1.  Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study.

Authors:  Barry L Pizer; Claire L Weston; Kathryn J Robinson; David W Ellison; James Ironside; Frank Saran; Linda S Lashford; Diana Tait; Helen Lucraft; David A Walker; Clifford C Bailey; Roger E Taylor
Journal:  Eur J Cancer       Date:  2006-04-24       Impact factor: 9.162

2.  Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children.

Authors:  Jacques Grill; Christian Sainte-Rose; Anne Jouvet; Jean-Claude Gentet; Odile Lejars; Didier Frappaz; François Doz; Xavier Rialland; Fabienne Pichon; Anne-Isabelle Bertozzi; Pascal Chastagner; Dominique Couanet; Jean-Louis Habrand; Marie-Anne Raquin; Marie-Cécile Le Deley; Chantal Kalifa
Journal:  Lancet Oncol       Date:  2005-08       Impact factor: 41.316

3.  Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

Authors:  P M Zeltzer; J M Boyett; J L Finlay; A L Albright; L B Rorke; J M Milstein; J C Allen; K R Stevens; P Stanley; H Li; J H Wisoff; J R Geyer; P McGuire-Cullen; J A Stehbens; S B Shurin; R J Packer
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

4.  Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.

Authors:  Ian F Pollack; Ronald L Hamilton; C David James; Sydney D Finkelstein; Judith Burnham; Allan J Yates; Emiko J Holmes; Tianni Zhou; Jonathan L Finlay
Journal:  J Neurosurg       Date:  2006-11       Impact factor: 5.115

5.  Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.

Authors:  R J Packer; J Ater; J Allen; P Phillips; R Geyer; H S Nicholson; R Jakacki; E Kurczynski; M Needle; J Finlay; G Reaman; J M Boyett
Journal:  J Neurosurg       Date:  1997-05       Impact factor: 5.115

Review 6.  A pooled analysis of extremely low-frequency magnetic fields and childhood brain tumors.

Authors:  Leeka Kheifets; A Ahlbom; C M Crespi; M Feychting; C Johansen; J Monroe; M F G Murphy; S Oksuzyan; S Preston-Martin; E Roman; T Saito; D Savitz; J Schüz; J Simpson; J Swanson; T Tynes; P Verkasalo; G Mezei
Journal:  Am J Epidemiol       Date:  2010-08-09       Impact factor: 4.897

7.  Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.

Authors:  Katja von Hoff; Wolfgang Hartmann; André Oscar von Bueren; Nicolas Ulrich Gerber; Michael Andreas Grotzer; Torsten Pietsch; Stefan Rutkowski
Journal:  Pediatr Blood Cancer       Date:  2010-03       Impact factor: 3.167

8.  A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood.

Authors:  Regina I Jakacki; Allan Yates; Susan M Blaney; Tianni Zhou; Robert Timmerman; Ashish M Ingle; Lynda Flom; Michael D Prados; Peter C Adamson; Ian F Pollack
Journal:  Neuro Oncol       Date:  2008-05-22       Impact factor: 12.300

9.  Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function.

Authors:  Thomas E Merchant; Chia-Ho Hua; Hemant Shukla; Xiaofei Ying; Simeon Nill; Uwe Oelfke
Journal:  Pediatr Blood Cancer       Date:  2008-07       Impact factor: 3.167

10.  Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons.

Authors:  Shannon M MacDonald; Sairos Safai; Alexei Trofimov; John Wolfgang; Barbara Fullerton; Beow Y Yeap; Thomas Bortfeld; Nancy J Tarbell; Torunn Yock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-03-05       Impact factor: 7.038

View more
  30 in total

Review 1.  Visual function in children with primary brain tumors.

Authors:  Jason H Peragallo
Journal:  Curr Opin Neurol       Date:  2019-02       Impact factor: 5.710

Review 2.  Overcoming the blood-brain barrier in chemotherapy treatment of pediatric brain tumors.

Authors:  Linfeng Wu; Xiaoxun Li; Dileep R Janagam; Tao L Lowe
Journal:  Pharm Res       Date:  2013-08-31       Impact factor: 4.200

3.  Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma.

Authors:  Smita K Nair; Timothy Driscoll; David Boczkowski; Robert Schmittling; Renee Reynolds; Laura A Johnson; Gerald Grant; Herbert Fuchs; Darell D Bigner; John H Sampson; Sridharan Gururangan; Duane A Mitchell
Journal:  J Neurooncol       Date:  2015-08-27       Impact factor: 4.130

4.  A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas.

Authors:  Yu Sun; John A Alberta; Catherine Pilarz; David Calligaris; Emily J Chadwick; Shakti H Ramkissoon; Lori A Ramkissoon; Veronica Matia Garcia; Emanuele Mazzola; Liliana Goumnerova; Michael Kane; Zhan Yao; Mark W Kieran; Keith L Ligon; William C Hahn; Levi A Garraway; Neal Rosen; Nathanael S Gray; Nathalie Y Agar; Sara J Buhrlage; Rosalind A Segal; Charles D Stiles
Journal:  Neuro Oncol       Date:  2017-06-01       Impact factor: 12.300

Review 5.  Effects of Brain Tumors on Vision in Children.

Authors:  Jason H Peragallo
Journal:  Int Ophthalmol Clin       Date:  2018

6.  SOX2 immunity and tissue resident memory in children and young adults with glioma.

Authors:  Juan C Vasquez; Anita Huttner; Lin Zhang; Asher Marks; Amy Chan; Joachim M Baehring; Kristopher T Kahle; Kavita M Dhodapkar
Journal:  J Neurooncol       Date:  2017-06-15       Impact factor: 4.130

7.  Absence of human cytomegalovirus infection in childhood brain tumors.

Authors:  Iacopo Sardi; Maurizio Lucchesi; Sabrina Becciani; Ludovica Facchini; Milena Guidi; Anna Maria Buccoliero; Maria Moriondo; Gianna Baroni; Alessia Stival; Silvia Farina; Lorenzo Genitori; Maurizio de Martino
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

8.  Quantifying radiation therapy response using apparent diffusion coefficient (ADC) parametric mapping of pediatric diffuse intrinsic pontine glioma: a report from the pediatric brain tumor consortium.

Authors:  Rafael Ceschin; Mehmet Kocak; Sridhar Vajapeyam; Ian F Pollack; Arzu Onar-Thomas; Ira J Dunkel; Tina Young Poussaint; Ashok Panigrahy
Journal:  J Neurooncol       Date:  2019-02-27       Impact factor: 4.130

9.  Relative ADC and Location Differ between Posterior Fossa Pilocytic Astrocytomas with and without Gangliocytic Differentiation.

Authors:  J H Harreld; S N Hwang; I Qaddoumi; R G Tatevossian; X Li; J Dalton; K Haupfear; Y Li; D W Ellison
Journal:  AJNR Am J Neuroradiol       Date:  2016-07-28       Impact factor: 3.825

Review 10.  Neurocognitive function after radiotherapy for paediatric brain tumours.

Authors:  Laetitia Padovani; Nicolas André; Louis S Constine; Xavier Muracciole
Journal:  Nat Rev Neurol       Date:  2012-09-11       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.